Idiopathic pulmonary fibrosis: Pathophysiology, cellular signaling, diagnostic and therapeutic approaches

Idiopathic pulmonary fibrosis: Pathophysiology, cellular signaling, diagnostic and therapeutic approaches

Idiopathic pulmonary fibrosis (IPF) is a life-threatening and progressive interstitial lung disease. Healthy pulmonary tissues were replaced by an altered extracellular matrix (ECM) and destroyed the alveolar architecture, which led to the disruption of gas exchange, decreased lung compliance, and u...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak:	Ilma Shakeel, Mohammad Afzal, Asimul Islam, Sukhwinder Singh Sohal, Md. Imtaiyaz Hassan
Formatua:	Artikulua
Hizkuntza:	English
Argitaratua:	Elsevier 2023-12-01
Saila:	Medicine in Drug Discovery
Gaiak:	Idiopathic pulmonary fibrosis Cellular signaling Biomarkers Kinases Drug target
Sarrera elektronikoa:	http://www.sciencedirect.com/science/article/pii/S2590098623000179

Antzeko izenburuak

Cellular and Molecular Mechanisms in Idiopathic Pulmonary Fibrosis
nork: Yihang Zhang, et al.
Argitaratua: (2023-01-01)

Diagnostic Approaches for Idiopathic Pulmonary Fibrosis
nork: Jae Ha Lee, et al.
Argitaratua: (2024-01-01)

Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challenges
nork: Spagnolo Paolo, et al.
Argitaratua: (2012-11-01)

Idiopathic pulmonary fibrosis - a disorder of alveolar wound repair?
nork: Swiss Medical Weekly
Argitaratua: (2003-07-01)

Management of Pulmonary Hypertension in Idiopathic Pulmonary Fibrosis
nork: Abdullah Rashed Alharbi
Argitaratua: (2024-10-01)

The Role of Microbiome and Virome in Idiopathic Pulmonary Fibrosis
nork: Paschalis Ntolios, et al.
Argitaratua: (2021-04-01)

Clinicopathological Outlines of Post-COVID-19 Pulmonary Fibrosis Compared with Idiopathic Pulmonary Fibrosis
nork: Roxana-Elena Cîrjaliu, et al.
Argitaratua: (2023-06-01)

Clinical course and management of idiopathic pulmonary fibrosis
nork: Caitlin Quinn, et al.
Argitaratua: (2019-12-01)

Safety and efficiency of therapy with modern preparations of idiopathic pulmonary fibrosis
nork: E. A. Strel’tsov
Argitaratua: (2018-03-01)

Pulmonary vascular dysfunction without pulmonary hypertension: A distinct phenotype in idiopathic pulmonary fibrosis
nork: Steven D. Nathan, et al.
Argitaratua: (2024-01-01)

Herbal Remedies Effective on Treating Idiopathic Pulmonary Fibrosis
nork: Aditi Chaudhary, et al.
Argitaratua: (2023-12-01)

Evaluation of repolarization dispersion in patients with idiopathic pulmonary fibrosis
nork: Ferhat Eyyupkoca, et al.
Argitaratua: (2022-06-01)

Idiopathic pulmonary fibrosis: the turning point is now!
nork: Manuela Funke, et al.
Argitaratua: (2015-05-01)

Molecular and Genetic Biomarkers in Idiopathic Pulmonary Fibrosis: Where Are We Now?
nork: Ioannis Tomos, et al.
Argitaratua: (2023-10-01)

Fibroblast activation protein is a cellular marker of fibrotic activity in canine idiopathic pulmonary fibrosis
nork: Elodie Rizzoli, et al.
Argitaratua: (2024-07-01)

Delineating excess comorbidities in idiopathic pulmonary fibrosis: an observational study
nork: Burcu Ozaltin, et al.
Argitaratua: (2024-06-01)

The incidence of acute exacerbation of idiopathic pulmonary fibrosis: a systematic review and meta-analysis
nork: Yan Wang, et al.
Argitaratua: (2024-09-01)

IDIOPATHIC PULMONARY FIBROSIS. CORRECTION OF ERRORS
nork: A. L. Yudin, et al.
Argitaratua: (2018-12-01)

Metabolic reprogramming in idiopathic pulmonary fibrosis
nork: DUAN Ran, LI Qingyuan, FENG Tong
Argitaratua: (2024-06-01)

Circulating MicroRNAs in Idiopathic Pulmonary Fibrosis: A Narrative Review
nork: Marisa Denisse Colin Waldo, et al.
Argitaratua: (2024-12-01)

Current state of signaling pathways associated with the pathogenesis of idiopathic pulmonary fibrosis
nork: Yang Zhou, et al.
Argitaratua: (2024-06-01)

The Impact of Chronic Comorbidities on Outcomes in Acute Exacerbations of Idiopathic Pulmonary Fibrosis
nork: Saqib H. Baig, et al.
Argitaratua: (2024-01-01)

Translating Idiopathic pulmonary fibrosis guidelines into clinical practice
nork: C. Robalo-Cordeiro, et al.
Argitaratua: (2021-01-01)

The Role of Immune Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis
nork: Yahan Xu, et al.
Argitaratua: (2023-11-01)

Idiopathic pulmonary fibrosis: Addressing the current and future therapeutic advances along with the role of Sotatercept in the management of pulmonary hypertension
nork: Dalia D. Hadi, et al.
Argitaratua: (2023-11-01)

Idiopathic Pulmonary Fibrosis and Post-COVID-19 Lung Fibrosis: Links and Risks
nork: Filippo Patrucco, et al.
Argitaratua: (2023-03-01)

The Genetic and Epigenetic Footprint in Idiopathic Pulmonary Fibrosis and Familial Pulmonary Fibrosis: A State-of-the-Art Review
nork: Claudio Tirelli, et al.
Argitaratua: (2022-12-01)

Identifying prothrombin and bone sialoprotein as potential drug targets for idiopathic pulmonary fibrosis
nork: Yusha Chen, et al.
Argitaratua: (2024-10-01)

Circular RNAs and their roles in idiopathic pulmonary fibrosis
nork: Akshaya Surendran, et al.
Argitaratua: (2024-02-01)

Prospects for Treatment of Idiopathic Pulmonary Fibrosis
nork: R. N. Mustafin
Argitaratua: (2022-08-01)

Comparison of the Effects of Nintedanib and Pirfenidone on Pulmonary Function Test Parameters and Radiological Findings in Patients with Idiopathic Pulmonary Fibrosis: A Real-Life Study
nork: Olcay Aycicek, et al.
Argitaratua: (2025-02-01)

Succinate promotes pulmonary fibrosis through GPR91 and predicts death in idiopathic pulmonary fibrosis
nork: Yijun He, et al.
Argitaratua: (2024-06-01)

Predictive biomarkers of disease progression in idiopathic pulmonary fibrosis
nork: Weiwei Zhu, et al.
Argitaratua: (2024-01-01)

The Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis, Familial Pulmonary Fibrosis and Progressive Fibrosing Interstitial Lung Diseases: A Real-World Study
nork: Paolo Cameli, et al.
Argitaratua: (2022-08-01)

Pulmonary Fibrosis and Progressive Pulmonary Fibrosis in a Prospective Registry of Interstitial Lung Diseases in Eastern Siberia
nork: Maria S. Nashatyreva, et al.
Argitaratua: (2023-01-01)

Potential role of SIRT-1 and SIRT-3 as biomarkers for the diagnosis and prognosis of idiopathic pulmonary fibrosis
nork: Fabio Perrotta, et al.
Argitaratua: (2024-04-01)

Effects of Pirfenidone on Idiopathic Pulmonary Fibrosis Progression and Safety: Results of Multicenter Prospective Observational Study
nork: Sergey Avdeev, et al.
Argitaratua: (2023-02-01)

Real-world practice of idiopathic pulmonary fibrosis: Results from a 2000–2016 cohort
nork: Wang Ying-Tso, et al.
Argitaratua: (2023-11-01)

Design of the STRIVE-IPF trial- study of therapeutic plasma exchange, rituximab, and intravenous immunoglobulin for acute exacerbations of idiopathic pulmonary fibrosis
nork: Tejaswini Kulkarni, et al.
Argitaratua: (2024-03-01)

Regulatory T Cell Phenotype Related to Cytokine Expression Patterns in Post‐COVID‐19 Pulmonary Fibrosis and Idiopathic Pulmonary Fibrosis
nork: Sara Gangi, et al.
Argitaratua: (2025-01-01)